The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
HSCS · Healthcare · No moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | HSCS | CELZ | BDX | RCEL |
|---|---|---|---|---|
| Moat Score (0–100) | 38 (highest) | 38 (highest) | 38 (highest) | 38 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 20 | 20 | 49 | 55 (highest) |
| Pricing power | 79 | 70 | 76 | 82 (highest) |
| Returns on capital | — | 0 (highest) | 0 (highest) | 0 (highest) |
| Balance-sheet safety | 28 | 55 (highest) | 10 | 28 |
| Capital allocation | 24 | 44 | 54 (highest) | 24 |
| No price data | No price data | 28% above value if growth stopped today | No price data | |
| Market cap | $7.6M | $3M | $44.6B | $141M |
| Moat tier | No moat | No moat | No moat | No moat |
| Filing date | FY2026 | FY2025 | FY2025 | FY2025 |